Answers are grounded in this paper and cite their sources.
Among patients with stage III colon cancer receiving adjuvant therapy with FOLFOX or CAPOX, noninferiority of 3 months of therapy, as compared with 6 months, was not confirmed in the overall population. However, in patients treated with CAPOX, 3 months of therapy was as effective as 6 months, particularly in the lower-risk subgroup. (Funded by the National Cancer Institute and others.).
No takes yet. Share an insight, caveat, or question.
Grothey et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: